Cleerly LABS vs HeartFlow Analysis

Both tools offer cloud-based, web applications with 3D visualization of coronary arteries. Cleerly highlights integration with PACS, RIS, EHR via a proxy and PowerScribe for streamlined reporting [cite: The structured facts, 26]. HeartFlow also integrates with PACS and HL7, and recently introduced an interactive platform with integrated FFRct values, suggesting a highly interactive user experience. Given both emphasize seamless integration and interactive visualization, it's difficult to definitively pick a winner without direct user feedback.

HeartFlow Analysis excels with its Fractional Flow Reserve derived from CT (FFRct), a non-invasive method to assess the functional significance of coronary blockages, which is considered a gold standard for ischemia detection [cite: The structured facts, 15]. It boasts extensive clinical validation in over 200 studies and is endorsed by NICE, ACC, and AHA. While Cleerly LABS offers comprehensive plaque characterization, tracking, and now ischemia detection, HeartFlow's established functional assessment provides a critical clinical insight for guiding revascularization decisions [cite: The structured facts, 15, 26].

HeartFlow Analysis has a significant advantage in pricing and value due to established Medicare and most U.S. commercial payer coverage for its FFRct analysis (CPT 75580) [cite: The structured facts]. It also has a Category I CPT code for plaque analysis (75577 for 2026) and has been deemed cost-effective by NICE [cite: The structured facts, 3, 7, 21]. Cleerly LABS, while now having a CPT code for plaque analysis and EviCore coverage, still notes that its analysis is often out-of-pocket for patients, making it less accessible financially [cite: The structured facts, 23, 28, 31, 33].

Both tools are FDA-cleared, HIPAA compliant, provide BAAs, and are cloud-based on AWS, indicating strong foundational readiness [cite: The structured facts]. However, HeartFlow demonstrates broader enterprise maturity with adoption by over 1,400 institutions globally and compliance with a comprehensive list of international security and data integrity standards, including HITRUST, SOC 2 Type 2, GDPR, and ISO certifications. Cleerly's explicit mention of PACS, RIS, EHR, and PowerScribe integration is strong, but HeartFlow's wider institutional adoption and extensive certifications give it an edge [cite: The structured facts, 5, 8, 26, 29].

HeartFlow's FFRct, which uses computational fluid dynamics to non-invasively assess the functional significance of coronary stenoses, was a groundbreaking innovation that transformed the diagnostic pathway for CAD [cite: The structured facts, 15, 24]. While Cleerly's comprehensive plaque characterization and progression tracking are highly innovative for personalized risk assessment, HeartFlow's pioneering functional assessment, backed by a vast data foundation and expansion into PCI planning, represents a more established and continuously evolving innovation in the field [cite: The structured facts, 5, 6, 15, 24].

HeartFlow provides explicit contact information for support, including an email and phone number, and offers patient-facing resources like information kits and a hospital finder tool. While Cleerly undoubtedly offers support, its publicly available information on dedicated support channels and documentation is less explicit. HeartFlow's transparent and accessible support resources for both clinicians and patients indicate a more robust support infrastructure.